Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Why the Guidance Raise Outweighs the Beat Lilly currently guides to 2026 revenue of $82 billion to $85 billion and non-GAAP EPS of $35.50 to $37.00, a range it raised by $2 billion alongside Q1
Its a simple, credible choice for UK patients who want structure and safety over extra features
Recent advances in the design of choline kinase inhibitors and the molecular basis of their inhibition
It offers a simple way to manage B12 needs and often works well to address deficiencies caused by diet
versus other countries
US$ 22.51
US$ 26.92
US$ 26.29
US$ 23.03
US$ 23.05
US$ 22.27
US$ 27.85
